Inogen | INGN - Selling And Administration Expenses


Inogen reported $43.77M in Selling and Administration Expenses for its fiscal quarter ending in June of 2024.





Selling And Administration Expenses Change Date
Abbott USD 3.6B 330M Jun/2026
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 36.57M 3.79M Sep/2025
Artivion USD 55.75M 4.54M Dec/2025
AtriCure USD 82.56M 1.99M Jun/2026
Baxter International USD 735M 7M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
Cooper Companies USD 676.2M 303.1M Mar/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Globus Medical USD 286.82M 10.95M Jun/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 344.8M 27.6M Jun/2026
Medtronic 3.06B 101M Mar/2026
Orthofix International USD 130.35M 11.31M Dec/2025
Philips EUR 1.21B 23M Jun/2026
ResMed USD 290.65M 10.86M Jun/2026
Steris USD 369.7M 17.9M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 111.64M 3.45M Jun/2026
Teleflex USD 213.52M 12.5M Jun/2026
X T L Biopharmaceuticals USD 706K 50K Dec/2024
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026